Chair(s): Torsten Gerriet Blum, Andriani Charpidou, Wouter H. van Geffen
Session type: Symposium
Session content
Didier Jean
Replay
Slides
Didier Schneiter
Replay
Slides
Dean Anthony Fennell
Replay
Slides
Discussion and Q&A
Replay
Session aims
To summarise progress made using tissue and imaging features, including use of artificial intelligence; to provide a staging update, including the value of ancillary tests, such as positron emission tomography-computed tomography and magnetic resonance imaging, and a summary of the 9th edition of the TNM algorithm, which will be published prior to congress; to cover radical therapeutic approaches, including a detailed review of the recent MARS2 surgical trial and adjuvant strategies; to provide a state-of-the-art summary of systemic therapeutic options, including 5-year survival data for combination immunotherapy and outcomes of biomarker-directed therapies emerging from the MIST (Mesothelioma Stratified Therapy) platform, which will both be available before the congress.